Detalhe da pesquisa
1.
Caregiver survey in glioblastoma focused on cognitive dysfunction: development and results from a multicenter study.
Future Oncol
; 19(2): 173-188, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36974606
2.
Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
Support Care Cancer
; 30(2): 1365-1375, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34510238
3.
Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 133-141, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31549264
4.
Correction to: Developing real-world comparators for clinical trials in chemotherapy-refractory patients with gastric cancer or gastroesophageal junction cancer.
Gastric Cancer
; 23(1): 142, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31679092
5.
Correction to: Caregiver burden by treatment and clinical characteristics of patients with glioblastoma.
Support Care Cancer
; 30(2): 1377-1378, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792647
6.
Characterizing fatigue associated with sunitinib and its impact on health-related quality of life in patients with metastatic renal cell carcinoma.
Cancer
; 120(12): 1871-80, 2014 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-24634003
7.
Retrospective observational cohort study on innovation in oncology and progress in survival: How far have we gotten in the two decades of treating patients with advanced non-small cell lung cancer as a single population?
PLoS One
; 15(5): e0232669, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32396541
8.
Comparative effectiveness of nivolumab versus clinical practice for advanced gastric or gastroesophageal junction cancer.
J Comp Eff Res
; 9(2): 103-114, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31872771
9.
Survival, costs, and health care resource use by line of therapy in US Medicare patients with newly diagnosed glioblastoma: a retrospective observational study.
Neurooncol Pract
; 7(2): 164-175, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32626585
10.
Treatment Patterns and Economic Burden by Lines of Therapy Among Patients with Advanced Hepatocellular Carcinoma Treated with Systemic Cancer Therapy.
J Gastrointest Cancer
; 51(1): 217-226, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-31011982
11.
Real-world treatment patterns, cost of care and effectiveness of therapies for patients with squamous cell carcinoma of head and neck pre and post approval of immuno-oncology agents.
J Med Econ
; 23(2): 125-131, 2020 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-31581922
12.
Comparative effectiveness of nivolumab versus standard of care for third-line patients with small-cell lung cancer.
J Comp Eff Res
; 9(18): 1275-1284, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33140652
13.
Cost-effectiveness analysis of nivolumab for the treatment of squamous cell carcinoma of the head and neck in the United States.
J Med Econ
; 23(5): 442-447, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-31928375
14.
Real-world Treatment Patterns and Clinical Outcomes Across Lines of Therapy in Patients With Advanced/Metastatic Gastric or Gastroesophageal Junction Cancer.
Clin Colorectal Cancer
; 19(1): 32-38.e3, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31813769
15.
A Real-World Claims Analysis of Costs and Patterns of Care in Treated Patients with Glioblastoma Multiforme in the United States.
J Manag Care Spec Pharm
; 25(4): 428-436, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30917077
16.
Real-World Clinical Impact of Immune Checkpoint Inhibitors in Patients With Advanced/Metastatic Non-Small Cell Lung Cancer After Platinum Chemotherapy.
Clin Lung Cancer
; 20(4): 287-296.e4, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31130450
17.
Tumor mutational burden in lung cancer: a systematic literature review.
Oncotarget
; 10(61): 6604-6622, 2019 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31762941
18.
Immunotargeted therapy in melanoma: patient, provider preferences, and willingness to pay at an academic cancer center.
Melanoma Res
; 29(6): 626-634, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-30688762
19.
Indirect comparison of nivolumab ± ipilimumab (CheckMate 032) versus other treatments for recurrent small-cell lung cancer.
J Comp Eff Res
; 8(10): 733-751, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31237143
20.
Safety, Efficacy, and Patient-Reported Health-Related Quality of Life and Symptom Burden with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer, Including Patients Aged 70 Years or Older or with Poor Performance Status (CheckMate 153).
J Thorac Oncol
; 14(9): 1628-1639, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31121324